semaglutide for alcohol rebound GLP-1 medications: The next big thing in use disorder treatment? – Recovery Research Institute GLP1 receptor agonists are supported

As a precaution, these medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Shorter needles (4-6 mm) are generally sufficient for subcutaneous injection in most patients and may reduce discomfort compared to longer needles

Because semaglutide is a potent medication, dosing errors, whether intentional or accidental, can lead to unintended exposure to higher amounts than planned and increase the risk of side effects

doi: 10.1111/dom.15031 14 NapoliRBerraCCatarigAMDi LoretoCDonatielloEBerentzenTLet al

Reduced appetite does not always lead to immediate weight loss